|
National Stock Number(NSN): 6505-01-380-9548 (6505013809548, 013809548)
| NIIN: |
01-380-9548 |
Item Name: |
ADENOSINE INJECTION |
INC: |
66550
|
| FSC: |
6505
|
Assignment Date: |
Oct-01-1993 |
CRIT: |
X |
IIG: |
66550 |
| ISC: |
2 |
Date Standardized: |
Oct-01-1993 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Feb-01-2006 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-530-3307 |
Item Name: |
ADENOSINE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Feb-01-2006 |
|
INC: |
66550 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
ADENOCARD |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
ADENOCARD |
39832
|
ASTELLAS PHARMA US, INC. |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
ADENOCARD INJECTION |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00469-0871-02 |
39832
|
ASTELLAS PHARMA US, INC. |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC00469-0872-02 |
39832
|
ASTELLAS PHARMA US, INC. |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC57317-0232-10 |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
P0-155 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$13.06 |
PG |
|
C2201X- |
Jul-01-1994 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$130.59 |
PG |
|
------- |
Jun-01-1995 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$130.59 |
PG |
|
9L----- |
Sep-01-1994 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$130.59 |
PG |
|
------- |
Sep-01-1994 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
SUBJECT TO DAMAGE BY FREEZING |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
2.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
ADENOSINE INJECTION USP 2ML SINGLE DOSE VIAL 10S |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
15.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.600 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
144 |
| FEAT |
SPECIAL FEATURES |
3 MG ADENOSINE PER ML |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUCB |
UNIT OF ISSUE CUBE |
0.004 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.100 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Sep-13-2003 |
3 |
H |
|
|
|
|
| FSKX |
|
Sep-13-2003 |
3 |
H |
|
|
|
|
| N9LM |
|
Sep-13-2003 |
3 |
H |
|
|
HD |
|
Replacement & Obsolete Information
| Obsolete NIIN Information |
|